Skip to main content
SpringerLink
Log in

Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Four different modes of TRH application (400 μg iv, 1 mg nasal, 10 mg buccal and 40 mg oral) were investigated in young healthy subjects for evaluation of thyrotropin (TSH) and prolactin (PRL) stimulation. Plasma TSH, PRL, T4, T3, thyroxine-binding-globulin (TBG) were measured by radioimmunoassay. There were significant increases of TSH and PRL following TRH stimulation by all test forms. Bolus injection of TRH led to maximal TSH and PRL plasma levels within 20 min to 30 min, compared with 30 min to 45 min following nasal administration. Buccal and oral application produced more prolonged TSH and PRL increases, achieving plateau levels after 120 min to 180 min. Stimulated PRL levels were higher in women than in men. Uniformity of PRL response was better after iv or nasal than buccal and oral TRH stimulation. Known side effects were lower after nasal than iv TRH application. Buccal and oral administration provoked no side effects. Nasal TRH application seems to be a well suited test form for TSH and PRL stimulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haigler E.D. jr., Pittman J.A. jr., Hershman J.M., Baugh Ch.M. Direct evaluation of pituitary thyrotropin reserve utilizing synthetic thyrotropin releasing hormone. J. Clin. Endocrinol. Metab. 33: 573, 1971.

    Article  PubMed  CAS  Google Scholar 

  2. Ormston B.J., Cryer R.J., Garry R., Besser G.M., Hall R. Thyrotropin-releasing hormone as a thyroid — function test. Lancet 2: 10, 1971.

    Article  PubMed  CAS  Google Scholar 

  3. Fleischer N., Lorente M., Kirkland J., Kirkland R., Clayton G., Galderon M. Synthetic TRH as a test of pituitary thyrotropin reserve. J. Clin. Endocrinol. Metab. 34: 617, 1972.

    Article  PubMed  CAS  Google Scholar 

  4. DeGroot L.J. Endocrinology. Grune-Stratton, New York, 1979, vol. 1, p. 197.

    Google Scholar 

  5. Madea K., Tanimoto K. Epileptic seizures induced by TRH. Lancet 1: 1058, 1981.

    Article  Google Scholar 

  6. Grussendorf R. V., Blittersdorf R., Raue R., Hüfner M. Severe complications after injection of TRH. Acta Endocrinol. (Kbh.) (Suppl.) 246: 82, 1972.

    Google Scholar 

  7. Staub J.J., Girard J., Gemsenjäger E. Entwicklung eines einfachen oralen Kurztest’s mit dem TSH-Releasing-Hormon (TRH) und dessen Anwendung in der Schilddrüsendiagnostik. Schweiz. Med. Wochenschr. 106: 1839, 1976.

    PubMed  CAS  Google Scholar 

  8. Rothenbuchner G., Birk J., Loos U., Raptis S., Pfeiffer E.F. The dynamics of TSH-secretion after oral administration of synthetic thyrotropin-releasing factor (TRF) in meta bolic normal subjects. Acta Endocdrinol. (Kbh.) (Suppl.) 159: 2, 1972.

    Google Scholar 

  9. Vogt P., Girard J., Staub J.J. Thyroid stimulating hormone (TSH), triiodothyronine (T3) and thyroxine (T4) response to intravenous and oral stimulation with synthetic thyrotropin-releasing hormone (TRH) in young healthy adults. Klin. Wochenschr. 56: 31, 1978.

    Article  PubMed  CAS  Google Scholar 

  10. Jüngst D., Sommerburg C, Braun S., Karl H.J. Stimulation von TSH durch TRH — ein Vergleich von intravenöser, oraler und intranasaler Applikation. Schild drüse 1981, 410. Thieme Verlag, Stuttgart, 1982.

    Google Scholar 

  11. Schäffgen W., Grebe S.F., Schatz H. Pernasal versus intravenous administration of TRH: Effects on thyrotropin, prolactin, triiodothyronine, thyroxine and thyroglobulin in healthy subjects. Horm. Metab. Res. 15: 52, 1983.

    Article  Google Scholar 

  12. Anders R. Selbsthaftende Polymerfilme zur bukkalen Applikation von Peptiden. Ph. D. Thesis, 1984, University of Bonn.

  13. Pérez-Lopez F.R., Gomez Agudo G., Abos M.D. Serum prolactin and thyrotropin responses to thyrotro pin-releasing hormone at different times of the day in normal women. Acta Endocrinol. (Kbh.) 97: 7, 1981.

    Google Scholar 

  14. Anders R., Merkle H.P., Schurr W., Ziegler R. Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin. J. Pharm. Sci. 72: 1481, 1983.

    Article  PubMed  CAS  Google Scholar 

  15. Assies J., Schellekens A.M., Touber J.L. The value of an intravenous TRH test for the diagnosis of tumoural prolactinaemia. Acta Endocrinol. (Kbh.) 94: 439, 1980.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine VI, Endocrinology, University of Heidelberg, Poliklinik., 6900, West Germany

    W. Schurr, B. Knoll &  R. Ziegler

  2. Pharmaceutical Institute, Pharmaceutical Technology, University of Bonn, West Germany

    R. Anders & H. P. Merkle

Authors
  1. W. Schurr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Knoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Anders
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. P. Merkle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schurr, W., Knoll, B., Ziegler, R. et al. Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects. J Endocrinol Invest 8, 41–44 (1985). https://doi.org/10.1007/BF03350636

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350636

Key-words

Search

Navigation